Skip to content

Enabling accurate quantitative small molecule biosensor assays with Optimer®

The accurate and sensitive detection of small molecules in point-of-care and in situ biosensor assays could enable faster and simpler analysis to extend diagnostic capabilities. The Optimer platform incorporates a discovery process that has been specifically designed to identify small molecule binding ligands.

Find out how:

  • Optimer biosensors meet the strict FDA requirements for ligand binding assays
  • Optimer ligands enable wearable and near-patient biosensors for small molecule drugs
  • High analytical sensitivity and selectivity are being met in single-plex and multiplex Optimer biosensors for small molecule analytes
  • Cross-validation with HPLC-MS shows excellent accuracy of Optimer biosensors

Download application guide

Start your next project with Aptamer Group

Contact one of our experts today